Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Natalia Reoutova, 06 Nov 2020

Researchers from the Hong Kong Baptist University (HKBU) have developed a novel contrast agent for brain MRI that enables real-time visualization and assessment of the size and number of amyloid-beta (Aβ) oligomers, a peptide that putatively plays a seminal role in synaptic loss in Alzheimer's disease (AD).

18 Nov 2020
Individuals with dry eye disease (DED) are less productive at work and have low activity levels, and the greater the severity of DED symptoms, the lower the productivity and activity, according to data from the Dry Eye Assessment and Management (DREAM) study.

COPD maintenance therapy with tiotropium/olodaterol vs LABA/ICS: A real-world study

22 Oct 2020
Interview with Professor Jennifer Quint from the Imperial College London, UK, on the role of tiotropium/olodaterol as chronic obstructive pulmonary disease (COPD) maintenance therapy in reducing the risk of escalation to triple therapy or development of adverse outcomes, as shown in a real-world study.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Hong Kong digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Natalia Reoutova, 06 Nov 2020

Researchers from the Hong Kong Baptist University (HKBU) have developed a novel contrast agent for brain MRI that enables real-time visualization and assessment of the size and number of amyloid-beta (Aβ) oligomers, a peptide that putatively plays a seminal role in synaptic loss in Alzheimer's disease (AD).

18 Nov 2020
Individuals with dry eye disease (DED) are less productive at work and have low activity levels, and the greater the severity of DED symptoms, the lower the productivity and activity, according to data from the Dry Eye Assessment and Management (DREAM) study.